Records 1 - 18
| GATA2 regulates the CAD susceptibility gene ADTRP rs6903956 through preferential interaction with the G allele.
Molecular genetics and genomics : MGG 2021 Apr .
Luo Chunyan, Tang Bo, Qin Subo, Yuan Chengfu, Du Youqin, Yang Ji
| Identification of cardiovascular health gene variants related to longevity in a Chinese population.
Aging 2020 Sep 12 .
Zhang Li, Bai Chen, Nie Chao, Zhu Xiaoquan, Yuan Huiping, Sun Liang, Zhou Qi, Li Xiaoling, Xian Xuan, Yang Fan, Pang Guofang, Lv Yuan, Ni Xiaolin, Hu Caiyou, Yang
| Association of TFPI polymorphisms rs8176592, rs10931292, and rs10153820 with venous thrombosis: A meta-analysis.
Medicine 2019 Mar 98 (12): e14978.
Zhang Yunhong, Pang Aimei, Zhao Lin, Guo Qiang, Zhang Zhen, Zhu Xiaoxiao, Wei Ran, Yin Xunqiang, Wang Bin, Li X
| A Prothrombotic Score Based on Genetic Polymorphisms of the Hemostatic System Differs in Patients with Ischemic Stroke, Myocardial Infarction, or Peripheral Arterial Occlusive Disease.
Frontiers in cardiovascular medicine 2017 4 39.
Herm Juliane, Hoppe Berthold, Siegerink Bob, Nolte Christian H, Koscielny Jürgen, Haeusler Karl Geo
| Single nucleotide polymorphisms in an intergenic chromosome 2q region associated with tissue factor pathway inhibitor plasma levels and venous thromboembolism.
Journal of thrombosis and haemostasis : JTH 2016 Oct 14 (10): 1960-1970.
Dennis J, Truong V, Aïssi D, Medina-Rivera A, Blankenberg S, Germain M, Lemire M, Antounians L, Civelek M, Schnabel R, Wells P, Wilson M D, Morange P-E, Trégouët D-A, Gagnon
| Determinants of acquired activated protein C resistance and D-dimer in breast cancer.
Thrombosis research 2016 Aug 145 78-83.
Tinholt Mari, Sandset Per Morten, Mowinckel Marie-Christine, Garred Øystein, Sahlberg Kristine Kleivi, Kristensen Vessela N, Børresen-Dale Anne-Lise, Jacobsen Anne Flem, Skretting Grethe, Iversen Ni
| Genetic determinants of tissue factor pathway inhibitor plasma levels.
Thrombosis and haemostasis 2015 Jul 114 (2): 245-57.
Dennis J, Kassam I, Morange P-E, Trégouët D-A, Gagnon
| Tumor expression, plasma levels and genetic polymorphisms of the coagulation inhibitor TFPI are associated with clinicopathological parameters and survival in breast cancer, in contrast to the coagulation initiator TF.
Breast cancer research : BCR 2015 17 44.
Tinholt Mari, Vollan Hans Kristian Moen, Sahlberg Kristine Kleivi, Jernström Sandra, Kaveh Fatemeh, Lingjærde Ole Christian, Kåresen Rolf, Sauer Torill, Kristensen Vessela, Børresen-Dale Anne-Lise, Sandset Per Morten, Iversen Ni
| Resistance to activated protein C is a risk factor for pregnancy-related venous thrombosis in the absence of the F5 rs6025 (factor V Leiden) polymorphism.
British journal of haematology 2011 Jul 154 (2): 241-7.
Bergrem Astrid, Dahm Anders Erik Astrup, Jacobsen Anne Flem, Mowinckel Marie-Christine, Sandvik Leiv, Sandset Per Mort
| Tissue factor pathway inhibitor polymorphisms in women with and without a history of venous thrombosis and the effects of postmenopausal hormone therapy.
Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis 2010 Sep 21 (6): 516-21.
Opstad Trine B, Eilertsen Anette L, Høibraaten Else, Skretting Grethe, Sandset Per Mort
| Association of Asn221Ser mutation in tissue factor pathway inhibitor-beta with plasma total tissue factor pathway inhibitor level.
Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis 2009 Jan 20 (1): 22-6.
Ishikawa Junko, Okada Hiromi, Kato Hisao, Takeshita Satoshi, Honda Shigenori, Kawasaki Tomio, Suehisa Etsuji, Tsuji Hajime, Madoiwa Seiji, Sakata Yoichi, Kojima Tetsuhito, Murata Mitsuru, Ikeda Yasuo, Kokubo Yoshihiro, Okamura Tomonori, Tomoike Hitonobu, Miyata Toshiyu
| Association analysis of tissue factor pathway inhibitor polymorphisms and haplotypes with osteonecrosis of the femoral head in the Korean population.
Molecules and cells 2008 Nov 26 (5): 490-5.
Dai Xue Lian, Hong Jung Min, Oh Bermseok, Cho Yoon Shin, Lee Jong-Young, Park Eui Kyun, Kim Chang Yoon, Kim Shin-Yoon, Kim Tae-
| Lack of association between thrombosis-associated and cytokine candidate gene polymorphisms and acute rejection or vascular complications after kidney transplantation.
Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 2008 Jan 23 (1): 364-8.
Alakulppi Noora S, Kyllönen Lauri E, Partanen Jukka, Salmela Kaija T, Laine Jarmo
| Polymorphisms of the tissue factor pathway inhibitor gene are associated with venous thromboembolism in the antiphospholipid syndrome and carriers of factor V Leiden.
Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis 2007 Sep 18 (6): 559-64.
Lincz Lisa F, Adams Murray J, Scorgie Fiona E, Thom Jim, Baker Ross I, Seldon Micha
| An unfavorable combination of Factor V Leiden with age, weight, and blood group causes high risk of pregnancy-associated venous thrombosis: a population-based nested case-control study.
Thrombosis research 2007 119 (4): 423-32.
Hiltunen Leena, Rautanen Anna, Rasi Vesa, Kaaja Risto, Kere Juha, Krusius Tom, Vahtera Elina, Paunio Mik
| Analysis of the tissue factor pathway inhibitor gene and antigen levels in relation to venous thrombosis.
British journal of haematology 2001 May 113 (2): 537-43.
Amini-Nekoo A, Futers T S, Moia M, Mannucci P M, Grant P J, Ariëns R
| The effects of hormone replacement therapy (HRT) on hemostatic variables in women with previous venous thromboembolism--results from a randomized, double-blind, clinical trial.
Thrombosis and haemostasis 2001 May 85 (5): 775-81.
Høibraaten E, Qvigstad E, Andersen T O, Mowinckel M C, Sandset P
| The C536T transition in the tissue factor pathway inhibitor (TFPI) gene does not contribute to risk of venous thrombosis among carriers of factor V Leiden.
Thrombosis and haemostasis 2000 Oct 84 (4): 724-5.
Hessner M J, Luhm R